Patients screened
Sites engaged
Studies enrolled
Countries supported
MMG’s “me” is a method powered by over 20 years of community-focused outreach to deliver clinical trial recruitment that overcomes the most critical enrollment barriers and achieves appropriate representation.
MMG tackles each of these barriers with:
Duke Clinical Research Institute (DCRI), in partnership with the Matthews Media Group Agency (MMG), received the MM+M Gold Award for the inclusion of diversity in clinical trial marketing. The objective of the MM+M Awards is to recognize, champion and celebrate creativity and effectiveness in healthcare marketing and communications.
An MM+M Award is valued because recognition comes from industry peers.
Why traditional engagement channels are not reaching patients:
Traditional methods have overestimated what patients will tolerate when it comes to communication channels.
Today’s preferred communication behaviors pivot around text messaging:
Conversational AI initiates patient engagement via text message and carries patients to IRB-compliant chat conversations that:
Today’s innovations accelerate patient engagement by generating educational content more quickly and efficiently than ever before.
Based on your priorities, we use proven data-backed strategies to help you reach your recruitment goals.
There are no shortcuts. Every patient, site, protocol, country, and study timeline has different needs.
Detailed profiles using multiple factors including diversity, prevalence, demographics, socioeconomic, behavior, and motivations
Incorporating insights that resonate with a global audience assessed though HCP and patient surveys, advisory groups, and market research
Full analysis of the protocol, patient, and landscape using our proprietary 10-point Recruitment Difficulty Scale
Utilizing social network data, influencers, trusted sources, and communities to inform creative messaging and content
Molly Matthews founded Matthews Media Group (MMG) in 1987 after a determined search to find a clinical trial option at the National Cancer Institute.
While her perseverance paid off for her family, she discovered a gap between life-changing clinical research and the patients and physicians who could benefit from it. Molly committed herself and MMG to closing that gap, and we are proud to advance the vision of clinical research as a care option.
The clinical trials we support benefit from our access to OHG's cutting-edge communication solutions and coveted partnerships in research, analytics, and digital technologies, as well as The Omnicom Group's vast buying power. We are privileged to scale these strengths to programs of all sizes.
MMG's leadership team drives our relentless commitment to being the most trusted clinical trial patient engagement partner with patients, caregivers, healthcare providers, research sites, partners, and clients.
Like our parent company, Omnicom Health Group under Omnicom, MMG is relentlessly pursuing progress and transformation. View Omnicom's Corporate Responsibility (CR) report .
MMG was founded on the belief of access for ALL in clinical trials. Our parent company, Omnicom Health Group under Omnicom, is just as passionate about Diversity, Equity, and Inclusion (DE&I). View Omnicom's Equity for ALL report .
Omnicom Health Group is the largest healthcare marketing and communications network in the world, with more than a dozen companies and over 4,000 talented people specializing in every area of health. See our sister agencies .
MMG has had a supplier diversity program since its inception. We use diverse vendors and small businesses as subcontractors, helping to sustain and encourage economic growth and combat economic inequality.
MMG holds GSA MAS contract 470RAA22D006L.
NAICS Codes: 54163, 54181, 54910
MMG is a large business.
MMG's broad and deep knowledge has been very valuable. They connected sites, patients, monitors, and sponsor with ease and efficiency, which is particularly appreciated given our trial intricacies and many fast-moving parts.
What sets MMG apart is commitment, collaboration, flexibility and ownership, and their openness to hearing and acting upon feedback in a professional and productive manner. They worked tirelessly to help us achieve our goals.
MMG are very collaborative, efficient, and proactive in the way they manage in the way they manage all aspects of enrollment support materials development and delivery, especially on large, complex global studies.
Please visit MyTrialSpot for a listing of trials supported by MMG. For a more complete directory of clinical trials please visit ClinicalTrials.gov.
Visit MyTrialSpot